Attovia Therapeutics, Inc.

NASDAQ:ATTO

Biotechnology

Healthcare
$15.53 -1.20%

-$0.18 today

Market cap
$709.92M
Beta
0.00
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $14.23High $28.00

Volume 0.34M

Average 0.45M

ATTO Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

Attovia Therapeutics, Inc.NASDAQ: ATTO

Effect of Forex Changes · Q2 FY2026 · quarter ended Jun 2026

Effect of forex changes of $0 in Q2 FY2026

Q2 FY2026 effect of forex changes was $0.

Context

  • Effect of forex changes amounted to 15.0% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$203K-99.1% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-99.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
203K USD
Year-over-year change
-99.1%
1-year CAGR
-99.1%

Effect of Forex Changes vs competitors

How ATTO compares with its peers on the latest reported figures

  • ATTO's FY2025 effect of forex changes of $203K is the 4th largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of -99.1% is the lowest of 4, against a peer median of +168.6%.
  • Effect of forex changes amounts to 15.0% of revenue for ATTO, versus a peer median of 0.5%.
ATTO Competitors Peer median
Effect of Forex Changes for ATTO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVMNEvommune, Inc.LTM Mar 2026$1.2M ——12.0%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$714K +11932.9%+406.4%—
CNTBConnect Biopharma Holdings LimitedFY2025$408K +168.6%-69.1%637.5%
ATTOAttovia Therapeutics, Inc.FY2025$203K -99.1%—15.0%
ALMSAlumis Inc. Common StockLTM Jun 2026$70K +119.6%—0.9%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$0 ———
ANABAnaptysBio, Inc.LTM Mar 2026$0 ——0.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
QTTBQ32 Bio Inc.LTM Mar 2026$0 ——0.0%
ZURAZura Bio LimitedLTM Mar 2026$0 ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ATTO) $0+168.6%+168.6%0.5%

Competitors are the stored peer set for ATTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Attovia Therapeutics, Inc.

NASDAQ:ATTO

Intrinsic Alpha fair value

Locked

Current Price

$15.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.